Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Table of Contents
Vol. 2, No. 3, 2011
Issue release date: September – December
Section title: Published: October 2011

Open Access Gateway

Case Rep Ophthalmol 2011;2:323–326

Tarantula Hairs as Corneal Foreign Bodies

Stagg B.C.a · Ambati B.K.b
aUniversity of Utah School of Medicine, and bUniversity of Utah Moran Eye Center, Salt Lake City, Utah, USA
email Corresponding Author

Brian Stagg

132 University VillageSalt Lake City, UT 84108 (USA)

Tel. +1 970 778 1258

E-Mail brian.stagg@hsc.utah.edu

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


Purpose: To report a case of tarantula hairs found in the cornea and discuss treatment. Case Report: A 16-year-old male presented with a 6-week history of right ocular irritation that began after letting his pet tarantula crawl on his face. Slit-lamp examination of the right eye revealed the presence of approximately 16 dark foreign bodies that had the appearance of small hairs. The foreign bodies were removed from the nasal region of the right cornea using Jewelers forceps, and the patient was prescribed a combination neomycin, polymyxin B, and dexamethasone ointment (Maxitrol®), given 4 times per day. Results: The patient presented for follow-up 2 weeks later, with resolution of symptoms. Conclusion: Effective treatment of keratitis caused by tarantula hairs includes taking a detailed history, conducting a careful slit-lamp examination, removal of any accessible hairs, and initiation of treatment with a topical steroid as determined by the clinical picture.

© 2011 S. Karger AG, Basel

Article / Publication Details

First-Page Preview
Abstract of Published: October 2011

Accepted: September 12, 2011
Published online: October 02, 2011
Issue release date: September – December

Number of Print Pages: 4
Number of Figures: 1
Number of Tables: 0

ISSN: (Print)
eISSN: 1663-2699 (Online)

For additional information: http://www.karger.com/COP

Open Access License / Drug Dosage / Disclaimer

Open Access License: This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.